Projects per year
Fingerprint
Dive into the research topics where Diane F Jelinek is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mayo Clinic Multiple Myeloma SPORE
Bergsagel, L., Braggio, E. D., Vachon, C. C. M., Chesi, M., Dueck, A., Fonseca, R., Geyer, S., Jelinek, D. F., Lacy, M. & Stewart, A. K.
9/1/15 → 8/31/24
Project: Research project
-
Developmental Research Program
Jelinek, D. F. & Jelinek, D. D. F.
9/15/21 → 8/31/23
Project: Research project
-
-
MECHANISMS OF CELL MYELOMA CELL GROWTH CONTROL
Jelinek, D. D. F. & Jelinek, D. F.
12/1/04 → 1/31/10
Project: Research project
-
-
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells
Wang, Z., Yan, H., Boysen, J. C., Secreto, C. R., Tschumper, R. C., Ali, D., Guo, Q., Zhong, J., Zhou, J., Gan, H., Yu, C., Jelinek, D. F., Slager, S. L., Parikh, S. A., Braggio, E. & Kay, N. E., Jul 2022, In: Blood cancer journal. 12, 7, 99.Research output: Contribution to journal › Article › peer-review
Open Access -
Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology
Hoelzinger, D. B., Quinton, S. J., Walters, D. K., Vardam-Kaur, T., Tschumper, R. C., da Silva, H. B. & Jelinek, D. F., Jun 14 2022, In: Blood Advances. 6, 11, p. 3458-3471 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial
Shanafelt, T. D., Wang, X. V., Hanson, C. A., Paietta, E. M., O'Brien, S., Barrientos, J., Jelinek, D. F., Braggio, E., Leis, J. F., Zhang, C. C., Coutre, S. E., Barr, P. M., Cashen, A. F., Mato, A. R., Singh, A. K., Mullane, M. P., Little, R. F., Erba, H., Stone, R. M., Litzow, M., & 2 others, Jul 14 2022, In: Blood. 140, 2, p. 112-120 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells
Tschumper, R. C., Hoelzinger, D. B., Walters, D. K., Davila, J. I., Osborne, C. A. & Jelinek, D. F., Feb 2022, In: Non-coding RNA. 8, 1, 15.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma
Sakemura, R., Hefazi, M., Siegler, E. L., Cox, M. J., Larson, D. P., Hansen, M. J., Manriquez Roman, C., Schick, K. J., Can, I., Tapper, E. E., Horvei, P., Adada, M. M., Bezerra, E. D., Kankeu Fonkoua, L. A., Ruff, M. W., Nevala, W. K., Walters, D. K., Parikh, S. A., Lin, Y., Jelinek, D. F., & 3 others, Jun 30 2022, In: Blood. 139, 26, p. 3708-3721 14 p.Research output: Contribution to journal › Article › peer-review
Open Access